Comparative Study Between Operative and Non-Operative Management of Femoral Shaft Fractures in Children (ESIN-THOMAS)

March 17, 2026 updated by: Ramy Ibrahim Mohamed Ibrahim, Cairo University

Comparative Study Between Operative Fixation With Elastic Stable Intramedullary Nails and Non-Operative Thomas Splint Traction in Pediatric Femoral Shaft Fractures

The goal of this clinical trial was to compare the management of pediatric femoral shaft fractures using either Thomas splint traction or Elastic Stable Intramedullary Nailing (ESIN).

The main questions it aimed to answer were:

Did ESIN provide faster fracture healing and earlier mobilization compared with Thomas splint traction?

Were there differences in complications and functional outcomes between the two treatment methods?

Researchers compared ESIN surgical fixation with Thomas splint traction to determine which treatment provided better clinical and functional outcomes in children with femoral shaft fractures.

Participants:

Were randomly assigned to receive either ESIN surgical fixation or Thomas splint traction.

Underwent regular clinical and radiographic follow-up to assess fracture healing, alignment, and recovery.

Were evaluated for complications, time to mobilization, functional outcomes, and treatment cost during the follow-up period.

Study Overview

Detailed Description

Femoral shaft fractures are among the most common major injuries in the pediatric population. The optimal method of treatment in children between 5 to 16 years remains a subject of ongoing debate, particularly in settings where surgical resources may be limited. Traditionally, conservative treatment using traction and immobilization methods such as the Thomas splint has been widely used. However, surgical fixation with Elastic Stable Intramedullary Nailing (ESIN) has gained popularity because it allows for stable fixation, earlier mobilization, and shorter hospital stay.

This randomized clinical trial was conducted at a single center, and the data were registered retrospectively after completion of patient enrollment and follow-up which aimed to compare the clinical and radiological outcomes of Elastic Stable Intramedullary Nailing (ESIN) versus Thomas splint traction in the treatment of pediatric femoral shaft fractures.

Eligible pediatric patients presenting with femoral shaft fractures were randomly assigned to one of two treatment groups. The first group was managed conservatively using Thomas splint traction according to standard protocols, while the second group underwent surgical fixation using ESIN.

Participants were followed clinically and radiographically at scheduled intervals to assess fracture healing, alignment, time to mobilization, and complications. Functional outcomes and adverse events were also documented and compared between the two groups.

The results of this study may help determine whether ESIN offers significant advantages over traditional conservative treatment with the Thomas splint in the management of pediatric femoral shaft fractures, particularly in healthcare settings where resources may vary.

Study Type

Interventional

Enrollment (Actual)

46

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • El Kasr El Aini Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • children aged 5 to 11 years
  • patients diagnosed with acute, closed and stable femoral shaft fractures (transverse, oblique or spiral patterns)
  • patients less than 45 kg in body weight.
  • Written informed consent obtained from parents or legal guardians.

Exclusion Criteria:

  • patients with open or pathological fractures.
  • patients with unstable (segmental or comminuted) fractures.
  • patient with proximal or distal physeal involvement.
  • patients with associated polytrauma, multiple fractures or neurovascular injury requiring urgent surgical intervention.
  • patients with neuromuscular or cognitive disorders.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Thomas splint treatment
Pediatric patients with fracture shaft femur were managed conservatively using Thomas splint, followed by standard post-splint care and follow-up.
Thomas splint is type of conservative treatment of different types of long bone fracture mostly lower limbs, it consists of traditional circular ring proximally
Experimental: Elastic Stable Intramedullary Nail (ESIN) Surgical Treatment.
Pediatric patients with fracture shaft femur were managed surgically using ESIN with standard pediatric orthopedic techniques.
ESIN is used in treatment of most of long bone fractures especially in pediatrics through minimally invasive incisions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to achieve fracture bone union radiologically
Time Frame: From treatment initiation to radiographic union, up to 12 weeks.
Time required for fracture healing as confirmed by radiographic evidence of bridging callus across the fracture site on follow-up radiographs.
From treatment initiation to radiographic union, up to 12 weeks.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to achieve full weight bearing
Time Frame: From treatment initiation to full weight bearing, up to 12 weeks.
Time from initiation of treatment until the patient is able to bear full weight on the affected limb without assistance.
From treatment initiation to full weight bearing, up to 12 weeks.
Incidence of complications
Time Frame: From treatment initiation up to 12 months.
Incidence of treatment-related complications such as infection, malunion, limb length discrepancy, or implant-related problems.
From treatment initiation up to 12 months.
Cost of treatment
Time Frame: From treatment initiation to hospital discharge (up to 7 days)
Total direct medical cost associated with treatment, including surgical procedure, hospital stay, implants, medications, and other related hospital expenses.
From treatment initiation to hospital discharge (up to 7 days)
Functional outcome according to Flynn's criteria
Time Frame: At 6 months,12 months, 2 years and 3 years.
Clinical outcome assessment based on Flynn's criteria, which evaluates limb length discrepancy, malalignment, pain, and complications. Results are categorized as excellent, satisfactory, or poor.
At 6 months,12 months, 2 years and 3 years.
Duration of hospital stay
Time Frame: From admission to discharge (up to 7 days)
Number of days the patient remains hospitalized from admission until discharge.
From admission to discharge (up to 7 days)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Hassan Magdy Elbarbary, MD, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 3, 2021

Primary Completion (Actual)

June 29, 2024

Study Completion (Actual)

June 29, 2024

Study Registration Dates

First Submitted

March 13, 2026

First Submitted That Met QC Criteria

March 17, 2026

First Posted (Actual)

March 19, 2026

Study Record Updates

Last Update Posted (Actual)

March 19, 2026

Last Update Submitted That Met QC Criteria

March 17, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All IPD collected throughout the trial including baseline characteristics, intervention details, follow-up data, and primary and secondary outcome measures will be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diaphyseal Femur Fracture

Clinical Trials on Thomas splint

Subscribe